T-DXd With or Without Bevacizumab for HER2-low Breast Cancer With Brain Metastasis
Clinical trial NCT07150208 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07150208
- Sponsor
- Fudan University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-01
- Primary completion
- 2027-09-01
- Enrollment
- 140
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.